Literature DB >> 352324

Changes in the activity of the reticulo-endothelial system of rats during an infection with T. lewisi.

A Ferrante, C R Jenkin, P C Reade.   

Abstract

Data presented show that during the course of a Trypanosoma lewisi infection in rats there was both an activation of the phagocytic cells of the liver and spleen and an increase in their numbers. There was a marked lymphoid hyperplasia in the white pulp of the spleen with an increase in the number and size of the lymphoid follicles. Degenerative changes occurred in the liver parenchymal cells during the infection, and at certain stages large numgers of mononuclear cells were observed in the vascular sinusoids and other vessels of the liver.

Entities:  

Mesh:

Year:  1978        PMID: 352324     DOI: 10.1038/icb.1978.6

Source DB:  PubMed          Journal:  Aust J Exp Biol Med Sci        ISSN: 0004-945X


  5 in total

Review 1.  Effector cells, molecules and mechanisms in host-protective immunity to parasites.

Authors:  G F Mitchell
Journal:  Immunology       Date:  1979-10       Impact factor: 7.397

2.  Growth of trypanosomes in vivo, host body weight gains, and food consumption in zinc-deficient mice.

Authors:  P A Humphrey; M Ashraf; C M Lee
Journal:  J Natl Med Assoc       Date:  1997-01       Impact factor: 1.798

3.  Identification of antibody classes and Fc receptors responsible for phagocytosis of Trypanosoma musculi by mouse macrophages.

Authors:  P Vincendeau; M Daëron; S Daulouede
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

4.  Interaction of nutrition and infection: effect of zinc deficiency on immunoglobulin levels in trypanosoma musculi infection.

Authors:  C M Lee; P A Humphrey; G F Aboko-Cole
Journal:  J Natl Med Assoc       Date:  1983-07       Impact factor: 1.798

5.  Lipopolysaccharide hyperreactivity of animals infected with Trypanosoma lewisi or Trypanosoma musculi.

Authors:  A Ferrante; R F Carter; J Ferluga; A C Allison
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.